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Desmosomes are specialized domains of the plasma mem-
bra?-e that playa fundamental role in intercellular adhesion. 
This adhesive functi.on is mediated at least in part by the 
cadherin homologous cell adhesion molecule (CAM) des-
rn~glein (dg). Autoantibodies (aab) from patients with pem-
phigus foliaceous (pf), a blistering disease of the epidermis, 
have been shown by immunochemical methods to bind to 
?esmoglein. However, the molecular localization of the bind-
Ing sites of these antibodies, especially as it relates to the 
ultrastructure of the desmosomes, has not been definitively 
characterized. We therefore performed pre-embedding di-
rect immunoelectron microscopy (IEM) on perilesional skin 
of patients with pf and post-embedding indirect IEM using 
sera from five patients with pf. We first confirmed by immu-
noprecipitation and immunoblotting that these sera bound 
dg. Both IEM methods showed that pf-aab exclusively bind 
to desmosomes. Double-labeling IEM of several other con-
stitutive desmosomal proteins further suggests that most 
likely pf-aab bind to an extracellular domain of the trans-
membrane CAM dg. Our studies suggest one possible patho-
physiologic mechanism for the clinical manifestations of pf: 
namely, that the binding of aab to an extracellular epitope of 
desmoglein might impair the adhesive properties of desmo-
somes mediated by dg and result in the loss of cell adhesion 
leading to acantholysis and blister formation.] Invest Dermatol 
99:323 - 330, 1992 
----------------------------------------------------------------------------------------------------------
Pemphigus vulgaris (pv) and pemphigus foliaceous (pf) are both autoimmune intraepidermal blist<:ring diseases in which antigen-antibody reactions are considered criti-cal events in the pathophysiology [1]. Despite the unify-ing designation "pemphigus," each type (pf/pv) has 
characteristic clinicopathologic and immunologic features [1- 6]; 
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however, several investigators repeatedly reported an identical im-
munomorphology, i.e., an "intercellular staining pattern," in pv 
and pf [7 - 11]. Both disorders have distinct and characteristic target 
antigens: pv autoantibodies (aab) immunoprecipitate a complex of 
polypeptides of 210 kD, 130 kD, and 85 kD of human epidermal 
extracts, whereas in pf the characteristic antigenic complex consists 
of polypeptides of 260 kD, 160 kD, 85 kD, and a minor polypep-
tide of 110 kD [12]. The 85-kD polypeptide in both the pv and pf 
antigen complexes is plakoglobin, a protein in the plaques of both 
types of adherens' junctions, involving actin-based microfilaments 
in intermediate-type junctions and intermediate filaments in des-
mosomes [13,14]. The 130-kD polypeptide, the actual binding site 
for the circulating pv-aab, was most recently identified as 'a novel 
epidermal cadherin [15]. Previous light microscopic and pre- and 
post-embedding !EM studies clearly have shown that this protein is 
uniformly expressed on the entire cell surface of epidermal keratino-
cytes [16,17] . In contrast, the aab characteristic ofrf patients have 
been shown to bind to the 160-kD component 0 the pf-antigen 
complex [13]. This transmembrane glycoprotein, termed dg, was 
the first constitutive desmosomal protein that was identified by 
molecular cloning as a member of the family of Ca++-dependent 
CAM, the cadherins [18-20] . 
In view of the seemingly contradictory findings of several im-
munomorphologic and biochemical studies regarding pf-aab and 
their interactions with desmosomes, we first tested pf sera by immu-
noprecipitation of human epidermal protein extracts and by im-
munoblotting using bovine desmosome preparations to confirm 
that the sera we used did, indeed, bind desmoglein. We then used 
immunofluorescence and IEM to immunolocalize accurately both 
the aab deposits in diseased skin of pf patients and the binding sites 
of the immunochemically characterized pf-aab in normal human 
skin, respectively. The aim of this study was to clarify, whether aab 
of pf patients bind to antigenic moieties, which are expressed uni-
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formly on the entire surface ofkeratinocytes as shown for pv aabs, or 
they are confined to desmosomes. If the latter assumption were true 
and because dg is a transmembrane glycoprotein, the binding sites of 
the aab could then either be located on the cytoplasmic desmosomal 
plaque, along the cytoplasmic membrane, within the extracellular 
desmoglea or even be distributed throughout the desmosome both 
extra- and intracellularly. To address this question, we first sought 
to clarify aspects of the morphomolecular organization of human 
epidermal desmosomes using immunomorphologic techniques on 
ultrathin cryosections; this method provides the requisite high reso-
lution to get insight into the macromolecular composition of des-
mosomes (21). For this study, we used monoclonal antibodies 
(MoAb) directed against the desmoplakin I/desmoplakin II (dpI/II) 
molecules and pg and the desmosomal transmembrane glycoprotein 
dg, as well as the immunochemically characterized sera from five 
patients with pf. Ultrastructural immunolocalization of the actual 
binding sites of pf-aab may provide further insight into the pathoge-
netic mechanisms operative in pf and in addition clarify aspects of 
cel l adhesion mediated by dg. 
MATERIALS AND METHODS 
Serum Samples and Antibodies Serum samples were obtained 
from five patients with clinically, histologically, and immunologi-
cally typical pf and from four healthy volunteers. 
Mouse MoAb were raised against the desmosomal plaque mole-
cules dpI/II; (dp 2.15), pg (pg 5.1), and the transmembrane desmo-
somal glycoprotein dg (dg 3.10). These antibodies are described in 
detail elsewhere [14,22-25). For immunofluorescence microscopy 
we used Texas Red-conjugated goat-anti-human IgG F(ab)z and 
fluorescein isothiocyanate - conjugated goat -anti-mouse IgG 
F(ab)z (Dia.nova, Hamburg, FRG). Pre-embedding IEM studies 
were performed with rabbit-anti-human IgG followed by swine-
anti-rabbit Ig using the peroxidase anti-peroxidase system (Dako-
patts, Copenhagen, Denmark). Post-embedding IEM was done 
using colloidal gold (5 nm and 10 nm) coated either with goat-
anti-mouse IgG or with protein A (Janssen Life Science Products, 
Beerse, Belgium). 
Immunoprecipitation of Epidermal Extracts Extraction of 
normal human epidermis, derived from suction blisters, and immu-
noprecipitation of these extracts were performed as previously de-
scribed in detail (26). CaCI2 was added to all extraction and immuno-
precipitation buffers, as described (26). Briefly, the epidermis was 
extracted with non-ionic detergent and the solubilized proteins 
were iodinated with 1251. After pre-absorbtion with normal human 
serum and protein A-bearing staphylococci, these labeled extracts 
were incubated with pf sera or, as controls, normal human sera; the 
antigen-antibody complexes were then precipitated with protein 
A-bearing staphylococci. The immunoprecipitated radiolabeled 
antigens were dissociated with sodium dodecyl sulfate (SDS) and 
dithiothreitol, separated by SDS - polyacrylamide gel electrophore-
sis (PAGE), and identified by autoradiography. 
Immunoblotting of Desmosomal Proteins Desmosomes 
were isolated from bovine muzzle epidermis as described in detail 
by Gorbsky and Steinberg [27,28). The constituent proteins were 
separated by SDScPAGE and then electrophoretically transfered 
to nitrocellulose (Schleicher & Schull, Dassel, FRG) using 
25 mM tris-buffered saline (TBS), pH 6.8, supplemented with 
1 mM dithiothreitol as blot buffer in a trans blot cell (Bio Rad 
Laboratories) at 40 volt for 2 to 4 h. The nitrocellulose blots were 
blocked with a solution of 1 % glycine, 3% bovine serum albumin 
(BSA), and 0.2% Tween 20 in TBS, pH 7.4, for 1 h at room temper-
ature or overnight at 4 ° C and then incubated with the pf sera di-
luted 1: 50 in TBS, pH 7.4, containing 3% BSA and 1 % glycine or 
with he MoAb diluted 1 :750 (dp 2.15 and pg 5.1) or 1: 1500 (dg 
3.10) for 1 h at room temperature. Subsequently the blots were 
washed six times with TBS, pH 7.4, containing 0.2% Tween 20, 
1 % BSA, and 1% glycine and then incubated with alkaline 
phosphatase-conjugated anti-mouse IgG or anti-human IgG re-
spectively (Dianova, Hamburg, FRG). After several washes in TBS 
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and distilled water the enzyme reaction product was visualized as 
described [29) . 
Light- and Electronmicroscopic Immunomorphology For 
the detection of in vivo bound IgG, biopsies were taken from penle-
sional skin of patients with pf and processed for light- (five panents) 
and electron microscopy (three patients) according to protocols r?U-
tinely used in our laboratory [11,30,31); briefly, for pre-embeddmg 
IEM, the specimens were washed in phosphate-buffered saline 
(PBS), pH 7.4 at 4 ° C for 60 min. Sections 60 11m thick wer~ ob-
tained with a Smith and Farquhar (S&F) tissue sectioner and mcu-) 
bated in PBS supplemented with 10% normal swine serum (NSS 
and 10% glucose for 1 h. We always performed this pre_incubatIOn 
step to reduce non-specific background staining. The pre-incuba-
tion was followed by incubation of the specimens with rabblt-
anti-human IgG (diluted 1: 100 in PBS, 5% NSS) for 3 h at room 
temperature followed by several washes in PBS/10% NSS; subse-
quently the specimens were incubated with swine-anti-rabblt Ig/ 
(diluted 1: 100 in PBS/5% NSS) and, after several washes m PBS 
10% NSS, incubated with the peroxidase-anti-peroxidase complex 
(diluted 1 : 100 in PBS). After several washes in PBS, the specimens 
were fixed in 1 % glutaraldehyde in PBS pH 7.4 for 2 h at ~oorn 
temperature, washed again in PBS and TBS, pH 6.8, and then m~u­
bated in 0.02% 3,3'-diaminobenzidine/hydrogen peroxide solution 
in TBS for 30-60 min. The tissue was post-fixed in 2% osmiUm 
tetroxide-potassium ferro cyanide for 60 min at 4 ° C and fur~he: 
processed for Epon 812 embedding. As controls a) some sectIOn 
were incubated in PBS only without the anti-human reagent and/or 
the anti-rabbit antibodies respectively, and b) shave biopsies from 
the epidermis of healthy humans were processed for !EM exactly as 
described above. d 
To demonstrate in vitro binding of pf-aab by indirect-IF, we used 
skin biopsies from healthy volunteers. These biopsies were dlvl~e 
so that post-embedding IEM studies could also be done. For t liS 
purpose, the tissue was placed into PBS, pH 7.4, and chopped into 
pieces of approximately 0.5 -1.0 mm3 and immersed in 2.3 M su-
crose in PBS for 20 min to improve the sectioning properties of the 
frozen tissue block and then mounted on pins, frozen, and stored 111 
liquid nitrogen. Ultrathin cryosections were cut at - 90°C to 
-105 °C on a Sorvall MT 5000 with a FS-1000 cryoattachmend 
using tungsten-coated glass knives . The sections were transfere d 
from the knive edge to previously glow-discharged formvar-coate 
gridS using a platinum loop containing a droplet of2.3 M sucrose~~ 
PBS, pH 7.4, and mounted section side down on a drop of P 
containing 50 mM glycine. After removal of the sucrose, the. secd 
tions were consecutively transfered to the immunoreagents dan 
washing media essentially as described by Tokuyasu [32). To re u~/ 
non-specific binding, the specimens were first incubated 111 PB 
50 mM glycine/10% fetal calf serum (FCS) and after 10 min trans-
ferred with forceps to 7 - 10111 droplets of the MoAb or the humfn 
aab diluted in PBS/50 mM glycine/5% FCS and incubated With t 1~ 
immunoreagents and controls, respectively, for 45 min. The an~b 
pg and anti-dpI/II MoAb were diluted 1 : 50 and the anti-dg Mo h 
was diluted 1: 100; all pf sera were diluted 1: 30. Thereafter t e ~ections were rinsed six times each time for 5 min in P~S and t~~~ 
1I1cubated on small drops of the Immunogold reagent diluted ~. by 
in PBS/lO% FCS. Unbound immunoreagents were remove ~ r 
washing for 15 min in PBS with three changes of the buffer. A te 
this step, in double-labeling experiments, the sections were illcud bated in PBS/10% Fes for 15 min and then consecutively expose 
to the second antibody (mouse MoAb) and the colloidal gold COllJu: 
gated goat-anti-mouse antibodies essentially as described for long 
olabeling. Unbound immunoreagents were removed by was lI~f 
for 15 min in PBS with three changes of the buffer and five [lnses d 
three minu.tes each in distilled water. The sections were staine~ ~/o 
embedded 111 an aqueous solution of 0.3% uranyl-acetate and . ·fic 
methylcellulose (Tylose MH 300, Fluka). As controls, the sped/Of 
first-step immunoreagents were replaced either with PBS all eC-
normal human serum and PBS and/or normal mouse serum, rTPeed 
tively. For a precise quantitation of the pf-aab binding, we se eC 
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only desmosomes that had been sectioned in a plane vertical to the 
plasma membrane of keratinocytes. Only such a plane of sectioning 
would allow optimal examination of the ultrastructural constituents 
of desmosomes [21 ,33J (see Fig 5E). For enumeration of bound gold 
particles, the desmosomes were divided into three distinct morpho-
morphologic areas: 1) the desmoglea, 2) the desmosomal cell mem-
brane, and 3) the intracellular desmosomal plaque. The number of 
gold particles indicating pf-aab binding over each of the three de-
fined desmosomal areas are reported as percentage of the total gold 
particles counted. For each pf serum tested, we counted 200 desmo-
somes (Table I). In addition, we counted all gold particles that were 
observed but without any definitive association with desmosomes. 
The sections were examined with a JEO L 100 ex or JEO L 1200 
EX electron microscope at 80 kV. 
RESULTS 
Iltununoprecipitatio~ and Immunoblotting These experi-
ments were done to demonstrate that the pf sera used in this study 
Irnrnunoprecipitated the previously described characteristic antigen 
cornplex [13 ,26J and bound to desmoglein, the 160 kD component 
In that complex. All of the sera from the five pf patients immunopre-
clpltated a complex of polypeptides that, when separated by SDS-
PAGE, dissociated into three m;yor polypeptides of 260 kD, 
160 kD, 85 kD, and a minor polypeptide of 110 kD (Fig 1). By 
Immunoblotting of bovine desmosomal extracts, sera of all five pf 
patients demonstrated a strong reactivity with a 160-kD polypep-
tide exclusively (Fig 2). This polypeptide comigrated with desmog-
leIn as demonstrated by staining with MoAb dg 3.10 (Fig 2). ~oAb 
raised against dp IIII and pg react specificially with protems of 
250 kD (dpI) and to a lesser extent with dpII (215 kD)and pg 
(85 kD), respectively [34J. Four control sera of healthy human vol-
Unteers showed no reactivity with dg by immunoblott1l1g. 
Iltllnultofluorescence Immunofluorescence (IF) using both pf 
sera and the MoAb against pg, dp IIII, and dg, respectively, on 
normal human skin generally showed a continuous staining of the 
~ell membranes of keratinocytes, identical to that reported as an 
Intercellular space" staining pattern of pemphigus [3,4J. In addi-
tion, in distinct areas of all sections we found a typical, punctate, 
desmosome staining of keratinocytes of normal human epidermis 
When labeled with the human pf serum andlor dp 2.15 andlor dg 
3.10, respectively. In double-labeling experiments we showed a 
cO- localization of the pf au toantigen and dg in a "pemphigus-type" 
pattern, simi lar to that reported previously [35J. However, these 
~o-localization studies also demonstrated a characteristic, punctate, 
esmosomal staining of several keratinocytes (Fig 3). 
Pre-embedding IEM Pre-embedding !EM has the disadvantage 
that antigenic domains within the cytoplasm may not be accessible 
th antibodies. Direct IEM of perilesional skin of pf patients revealed 
t at the aab were confined to desmosomes: peroxidase reaction prod-
UCt indicated in vivo bound IgG along the cell membrane and 
Within th e extracellular space of desmosomes, the desmoglea. Aab 
~ere detected in both disrupted and intact desmosomes (Fig 4 A,B). 
hese parts of the cell membranes of epidermal keratinocytes, 
which were devoid of desmosomes, as well as the adjacent extracel-
Table I. Number of Gold Particles Indicating 
Binding of PF-AAB ----------------------~------------------------
p . 
atlent Count (%) Desmosomal Cell Membrane (%) Desmoglea (%) 
Desmosomal 
Plaque (%) 
------------------------------------------------
I 1367 (100) 
2 1088 (100) 
3 1211 (100) 
4 856 (100) 
5 1155(100) ~5677(IOO) 
821 (60) 
631 (58) 
752 (62) 
479 (56) 
716 (62) 
3399 (60) 
519 (38) 
414 (38) 
423 (35) 
326 (38) 
427 (37) 
2129 (37) 
27 (2) 
43 (4) 
36 (3) 
51 (6) 
12 (1) 
169 (3) 
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Figure 1. Immunoprecipitation. Immunoprecipitation of human epider-
mal protein extracts with four different pf sera (Ialles 1-4). All sera precipi-
tate the previously described complex of 260 kD , 160 kD, dg, and 85 kD, 
pg (arrows). A fifth serum used in this study precipitated the same complex 
(not shown). 
a b 2 3 4 5 dp dg pg co co 
Figure 2. Immunoblotting. Bovine snout desmosomal proteins were sepa-
rated by SDS-PAGE, blotted to nitrocellulose, and reacted with pf sera and 
MoAb respectively. Lalles 1 - 5 show the reaction of pf-aab of five pf patients 
with the 160-kD glycoprotein (dg). Lanes designated dp, dg, and pg repre-
sent the labeling with the respective MoAb (anti-dp, anti-dgl/II, and anti-
pg). Lanes designated co show the immunoblots with sera from healthy 
human volunteers; no reaction with any protein band is observed. Lalle a, 
molecular weight standards from top to bottom: 205 kD , 116 kD, 97 kD, 
66 kD, 45 kD, 29 kD. Lalle b, Comassie Blue staining of major polypeptides 
of desmosomes; asterisks mark from top to bottom the positions of dp I, dplI, 
dg, desmocollin I, desmocollin II, pg (band 5), and band 6 polypeptide. 
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Figure 3. Indirect immunofluorescence. Double labeling of human epider-
mis with MoAb dg 3.10 (A) and pf serum (B) . Note the punctate desmoso-
mal staining pattern and colocalization of desmoglein and pf antigen (arrow-
heads). Magnification X660. 
lular space did not stain for in vivo bound IgG-aab. The negative 
controls also did not show any peroxidase positive reaction. product. 
Post-embedding IEM on Ultrathin Cryosections 
Morphology: Examination of ultrathin frozen sections of normal 
human skin revealed an almost identical desmosomal morphology 
as observed in plastic embedded tissue. The electron-dense cytoplas-
mic desmosomal plaque with the keratin filaments assembling at its 
inner surface was clearly defined (Fig 5C -1); the cytoplasmic mem-
brane appeared as an electron lucent cleft between the plaque and 
the intercellular space and was mostly preserved over the entire 
keratinocyte surface (Fig 5) . The extracellular space between the 
two opposing membranes of the desmosome, the desmoglea, ap-
peared slightly electron dense (Fig SA -H). In contrast to tissue 
embedded in plastic resins such as Epon 812 and Lowicryl K4M, a 
desmosomalmidline could not be observed [36]. The intercellular 
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Figure 4. Pre-embedding IEM. Note that the peroxidase positive reactil~ 
products (arrows), which indicate in vivo bound aab, are confined exclu.~ven 
to desmosomes. Cell membranes devoid of desmosomes do not exhl It III 
vivo bound IgG (arrowheads). The desmosomes appear either split (A) or stl 
intact (B). KF, keratin filaments. Magnification X30,000; bar = 300 nm· 
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:igure .5. Post-embedding IEM. Demonstration of in vitro binding of pf-aabs to the desmoglea and the desmosomal cell membrane. Expression of the pf 
aUtoantlgen within the desmoglea (arrolll G) in the stratum corneum (A) and within the transitional cell layer (B): the cornified envelope is marked with 
towheads. C, D, E, F show desmosomes of the granular and spinous cell layer: labeling of the pf autoantigcn is restricted to the desmoglea (G) and the 
v~srnosomal cytoplasmic membrane (M) . Double labeling of the pf autoantigen and dp lin, pg, and dg is shown in G,H,!. The binding of human pf-aab is 
blsuahzed using 10-nm gold particles, and 5-nm gold particles are used to indicate the binding sites of the MoAb dp 2.15 (G), pg 1.5 (H) and dg 3.10 (I): pf i~~?lng IS localized within the desmogleal desmosomal cell membrane, the MoAb recognize epitopes situated on the desmosomal plaque. The arrolllhead in H 
xzlCates that the cell membrane ofkeratinocytes is also well preserved where desmosomes are not present. Magnifications: A,B X 100,000, bar = 100 11m; C 
50,000, bar = 50 nm; D,E,F X200,OOO, bar = 50 nm; G,H,I X150,000, bar = 100,000 nm. 
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spaces between membranes, which were not occupied by desmo-
somes, was electron lucent. Size measurements of the desmosome 
and its component parts gave results similar to those of Epon and 
Lowicryl K4M embedded tissue: the desmosomal plaque measured 
approximately 25 to 30 nm and the desmoglea was 30 to 40 nm 
wide (Fig 5E). 
Immun%ca/ization Studies: The major advantage of this method is 
that the entire surface of the sections including the cytoplasm and 
inner sheet of the cell membrane is antibody accessible. The ultra-
structural binding sites of the three MoAb could be clearly localized 
to the cytoplasmic desmosomal plaque. The epitope(s) recognized 
by dp 2.15 and dg 3.10 were both localized to the cytoplasmic 
region of the desmosomal plaque (Fig 5(;,1). The localization of 
plakoglobin was found to be evenly distributed throughout the 
cytoplasmic plaque (Fig 5H). A uniquely different pattern of stain-
ing was observed using the sera from the five pf patients. The stain-
ing was equally distributed throughout the epidermis and could 
even be demonstrated within the stratum corneum (Fig SA) and the 
transitional cell layer (Fig 5B). Figure 5C - I demonstrate desmo-
somes of the granular and spinous cell layer. Sixty percent of gold 
particles was observed along the cell membranes of desmosomes. 
These gold particles showed a more intimate association with the 
desmoglea, i.e., the extracellular space than with the desmosomal 
plaque, i.e., the cytoplasm. Thirty-seven percent of the gold parti-
cles was observed within the desmoglea. Only 3% of the gold parti-
cles was found within the cytoplasmic plaque (Table I). Portions of 
the cell membrane ofkeratinocytes that were devoid of desmosomes 
did not show any pf-aab binding. Additionally, single gold particles 
were observed without any clear association with desmosomal 
structures, but irregularly dispersed throughout the sections and 
thus considered as non-specific background (this count is not in-
cluded in Table I). We did not observe labeling ofhemidesmosomes 
with any of our pf sera. All negative controls yielded negative re-
sults. 
DISCUSSION 
In the present study we confirmed in immunoprecipitation and 
immunoblotting experiments that the sera of five different patients 
with pf bind to human and bovine desmoglein. These sera were 
further used for immunomorphologic studies. On the first view 
only, indirect immunofluorescence with pf sera and the MoAb dp 
2.15 and dg 3.10 revealed a continuous staining of the cell bounda-
ries, identical to what is known as "pemphigus-type" continuous 
staining of the intercellular spaces [1- 6]. However, careful exami-
nation of these specimens revealed a clear, punctate desmosomal 
staining of several keratinocytes even on the light-microscopic level 
(Fig 3). A similar dotted, desmosomal immunomorphology was 
reported after labeling of murine epidermis with human pf-aab and 
of certain epithelial cell cultures stained with dp 2.15 and dg 3.10 
[8,22,25]. Pre- and post-embedding IEM studies further supported 
the light-microscopic findings: in perilesional skin of pf patients in 
vivo bound aab were confined to the desmoglea and the desmosomal 
cell membrane. Adjacent parts of the cell membrane that were not 
occupied by desmosomes were devoid ofIgG deposits. The desmo-
somes that exhibit~d aab binding appeared either intact or showed 
splitting within the desmoglea (Fig 4). Post-embedding !EM using 
ultracryomicrotomy has previously not been performed extensively 
in cutaneous pathology. Using this novel technique we were able to 
show that the actual binding sites of aab characteristic of pf patients 
in normal human skin in vitro is also essentially restricted to the 
extracellular space, the desmoglea (37%), and the cell membrane 
(60%). A majority of the membrane bound gold particles showed a 
close association with the desmoglea. This localization strongly 
suggests that pf-aab bind to an antigen closely related to the surfacej 
outer leaflet of the desmosomal cell membrane. Thus, we are 
tempted to speculate that 97% of gold particles indicates that the pf 
autoantigen is localized on the extracellular desmosomal surface 
within the desmoglea. Only a minute amount of gold particles was 
observed over the cytoplasmic plaque; one could explain this partic-
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ular localization by large antibody immunogold complexes that 
extend from the extracellular space into the cytoplasm. 
Summarizing the data from biochemical and immunomorfJholo-
gic studies, we clearly demonstrated that the pf serajaab usedm thIS 
study a) immunoprecipitate and react by immunoblotting wIth the 
transmembrane desmosomal cadherin homologous CAM dg; b) re-
veal a punctate, desmosomal IF staining of normal human .skm; c~ 
are found within intact and split desmosomes in patients, In VIVO] 
and d) bind exclusively to the desmoglea and the desmosomal cel 
membrane, in vitro. These results are in accordance with rece,nt 
biochemical experiments that show that pf-aab bind to a tryptiC, 
Ca++-sensitive glycopeptide derived from normal human and mur-
ine skin [37 - 39]. However, together with these findings, our study 
provides the immunomorphologic evidence that this glycopeptide 
is indeed expressed in desmosomes exclusively and most likely sug-
gests an extracellular domain of dg as the actual binding site of the 
pf-aab. Thus, the findings of this study demonstrate that pf IS not 
only defined by distinct clinical, histopathologic, and biochemIcal 
criteria, but is also characterized by a typical immunomorp.hologYr 
The extracellular part of desmosomes consists biocheinIcaJly 0 
the transmembrane core glycoproteins dg and desmocoJlins for 
which adhesive functions have been inferred [40,41] . More re-
cently, both glycoproteins have been identified by molecular clon-
ing as members of the cadherin family of CAM [18,19,42-45]. Tlll~ 
makes it quite likely that the establishment and maintenance of ce~ 
adhesion by desmosomes are mediated, at least in part, via dg an 
desmocollins, respectively, in a homophilic cad herin-type manner 
(46 - 50). Previous ultrastructural studies in pf confined the earlIest 
pathologic changes to desmosomes [51] . These data and the present 
findings strongly suggest that pf-aab subvert the interactions be-
tween dg molecules, which consequently lead to a loss of the adhe-
sive properties of desmosomes resulting in acantholysis and blIster 
formation [11]. The presence of acantholysis exclusively WIthIn the 
granular cell layer still remains enigmatic. However, it has been 
reported that the number of desmosomes is increased in the granular 
cell layer and that desmosomal proteins undergo profound biOchemj 
ical changes during differentiation (e.g., increase in dg content 
[35,51]. This may indicate that desmosomesjdg playa crUCial roe 
in cell adhesion in more differentiated cell layers of the epidermIS 
(e.g., the granular cell layer) . 9] 
The elucidation of the complete primary structure of dg [18,1 
and the important molecular topologic information that has been 
I . per deduced therefrom [18,19] and the results presented in t llS p~ 
regarding the ultrastructural localization of the pf autoantIgen 
within the desmoglea and desmosomal parts of the cell memb:anes 
are important steps toward determining if there is a unique el?ltoP[ 
of dg involved in the pathogenesis of pf. The precise localization 0 
the pf autoantigen within the primary structure of dg would I~ave 
important immunologic significance and therapeutic implicatIOnr 
and may suggest novel therapeutic strategies for the management 0 
this serious skin disease. 
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